Form 4 for BBNX Beta Bionics, Inc.
Accepted 2026-09-23 17:40:52 ET · period of report 2026-09-22 · accession 0002048467-26-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-23 17:40 | 2026-09-22 | BBNX | Jones Christy | Dir | S - Sale | $23.00 | -6,430 | 19.6K | -25% | -$147.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-22 | S | D | 6,430 | $23.00 | 19,564 | D | — | — | (F1) Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026. |